European Archives - Page 154 of 1053 - European Medical Journal

Hyperkalemic Paralysis by Addisonian Crisis: A Near Fatal Accident

This case report presents an unusual clinical scenario where a patient experienced temporary paralysis of his lower limbs while driving…

Orange lungs on yellow background

Sanofi and Regeneron's allergy drug is first biologic for COPD

Sanofi and Regeneron have announced that dupilumab has received an FDA approval in COPD and an eosinophilic phenotype.

Researchers Discover the Best Drug for Migraines

A study has revealed triptans are the most effective medicine for adults experiencing acute migraines – specifically, eletriptan, rizatriptan, sumatriptan, and zolmitriptan.

Risk of Second Primary Malignancies After CAR-T Therapy

A study has raised awareness about the risk of second primary malignancies in patients treated with chimeric antigen receptor T-cell therapy for hematologic cancers

Frailty and Age Increase Risks in Older Patients With Vasculitis

Frailty, more than age, significantly impacts the risk of severe infections in older adults with ANCA-associated vasculitis, according to a new study

HEAR-MHE Study: Automated Speech Analysis to Predict Hepatic Encephalopathy

A novel automated speech analysis platform has been developed to test for minimal hepatic encephalopathy (HE) and to predict overt HE in patients with cirrhosis.

From the Lab: Integrating Chemokines and Machine Learning in Primary Immune Thrombocytopenia

A new study has highlighted chemokines as potential biomarkers that could enhance the diagnosis and bleeding evaluation in patients with primary immune thrombocytopenia

Endoscopic Submucosal Dissection Effective for Colitis-Associated Neoplasia

A multicentre study shows endoscopic submucosal dissection is a safe, effective treatment for high-risk colorectal neoplasia in patients with inflammatory bowel disease.

GLP-1 Agonists Reduce Risk of Cirrhosis in Patients with MASLD

Researchers have discovered that the use of glucagon-like peptide 1 receptor agonists in patients with MASLD is linked to a significant reduction in the risk of developing cirrhosis and its complications.

COVID-19 Vaccinations Well-Tolerated Among Patients with Systemic Sclerosis

A study from SPIN shows that most individuals with systemic sclerosis are vaccinated against COVID-19, with minimal severe side effects and low rates of disease flare-ups.